findmyKOL

Emily Weis, MD

Basic profile

University of Rochester Medicine

ORCIDNone on fileNPI↗
✓ Full record
RegionRochester, NY · NortheastSpecialtyAllergy & ImmunologyFocusRheumatology/Immunology
Active KOLfindmyKOL type: RegionalLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Emily Weis is a Rheumatology/Immunology physician affiliated with University of Rochester Medicine. OpenAlex indexes 10 publications with 261 citations (h-index 3).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
10publications

Distinct works indexed by OpenAlex.

261citations

Total citations across indexed works.

3h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
6companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

300 Meridian Centre Blvd
Suite 300
Rochester, NY 146183981

Telephone

585-442-0150

Registry record last updated 6 Jul 2023.

View the NPPES registry record

Industry payments

6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Respiratory

    82.7%
    Histamine-1 Receptor Antagonist22.2%
    Levocetirizine Dihydrochloride62%Azelastine Hcl38%
    Part D<11 patients
    Corticosteroid18.7%
    Fluticasone Propionate34%Qvar Redihaler29%Breo Ellipta20%Arnuity Ellipta17%
    Part D<11 patients

    + 4 more classes in this area

  • Dermatology

    7.2%
    Interleukin-4 Receptor alpha Antagonist7.2%
    Dupixent Pen100%
    Part D<11 patients
  • Anti-infectives

    5.5%
    Macrolide Antimicrobial5.5%
    Azithromycin100%
    Part D<11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”